Johnson & Johnson (JNJ) is a leading healthcare company headquartered in New Brunswick, New Jersey. The company is known for its research and development, manufacturing, and sale of various healthcare products worldwide. With a market capitalization of $366.4 billion, Johnson & Johnson operates through its Innovative Medicine and MedTech segments.
The company is gearing up to announce its second-quarter results on Wednesday, July 16. Analysts are projecting a non-GAAP earnings of $2.65 per share, a 6% decrease from the previous year. Despite the anticipated decline, Johnson & Johnson has consistently exceeded analysts’ expectations in recent quarters. For the full fiscal year 2025, earnings are expected to reach $10.60 per share, representing a 6.2% increase from the previous year. In fiscal 2026, earnings are projected to rise by 3.6% year-over-year to $10.98 per share.
Over the past 52 weeks, JNJ stock has shown a 3.5% growth, outperforming the Health Care Select Sector SPDR Fund’s 8.1% decline but falling short of the S&P 500 Index’s 12.1% increase during the same period. Despite delivering better-than-expected financial results in the first quarter, Johnson & Johnson’s stock experienced a slight dip initially. However, the company’s solid growth in US sales led to a 2.4% year-over-year increase in overall revenue to $21.9 billion. Additionally, adjusted earnings per share rose by 2.2% to $2.77, exceeding consensus estimates.
Analysts have a cautiously optimistic outlook on JNJ, with a “Moderate Buy” rating overall. Of the 23 analysts covering the stock, nine rate it as a “Strong Buy,” two as a “Moderate Buy,” and 12 as a “Hold.” The mean price target of $169.14 suggests an 11.3% upside potential from the current price levels.
In conclusion, Johnson & Johnson continues to demonstrate resilience and growth in the healthcare industry. Investors are eagerly awaiting the company’s upcoming earnings report to gain further insights into its financial performance and future outlook. This article was originally published on Barchart.com and is intended for informational purposes only.
